The latest closing stock price for Monopar Therapeutics as of May 20, 2025 is 36.90.
An investor who bought $1,000 worth of Monopar Therapeutics stock at the IPO in 2019 would have $-722 today, roughly -1 times their original investment - a -22.56% compound annual growth rate over 5 years.
The all-time high Monopar Therapeutics stock closing price was 135.00 on December 20, 2019.
The Monopar Therapeutics 52-week high stock price is 54.30, which is 47.2% above the current share price.
The Monopar Therapeutics 52-week low stock price is 1.72, which is 95.3% below the current share price.
The average Monopar Therapeutics stock price for the last 52 weeks is 19.61.
An investor who bought $1,000 worth of Monopar Therapeutics stock at the IPO in 2019 would have $-722 today, roughly -1 times their original investment - a -22.56% compound annual growth rate over 5 years.
The all-time high Monopar Therapeutics stock closing price was 135.00 on December 20, 2019.
The Monopar Therapeutics 52-week high stock price is 54.30, which is 47.2% above the current share price.
The Monopar Therapeutics 52-week low stock price is 1.72, which is 95.3% below the current share price.
The average Monopar Therapeutics stock price for the last 52 weeks is 19.61.